The DEN and CCl4-induced mouse model of fibrosis and inflammation-associated hepatocellular carcinoma

Current Protocols in Pharmacology

Volumn 2014, Issue , 2014, Pages 14.30.1-14.30.10

  Uehara, Takeki ^a,b   Pogribny, Igor P ^c   Rusyn, Ivan ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b SHIONOGI AND CO LTD   (Japan)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Cancer; Fibrosis; Genotoxic; Liver; Mechanisms

Indexed keywords

BROXURIDINE; CARBON TETRACHLORIDE; DIETHYLNITROSAMINE; CARCINOGEN;

ARTICLE; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CHEMICAL CARCINOGENESIS; CHRONIC INFLAMMATION; DIMETHYLNITROSAMINE-INDUCED LIVER FIBROSIS; EPIGENETICS; FIBROGENESIS; HEPATITIS; HISTOPATHOLOGY; HUMAN; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER WEIGHT; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; MOUSE MODEL; MURINE MODEL; NONHUMAN; PRECANCER; PRIORITY JOURNAL; SCORING SYSTEM; ANIMAL; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; EXPERIMENTAL LIVER NEOPLASM; LIVER; LIVER CIRRHOSIS; MALE; MOUSE; PATHOLOGY;

ANIMALS; CARBON TETRACHLORIDE; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CHEMICAL AND DRUG INDUCED LIVER INJURY; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE;

EID: 84949309798     PISSN: 19348282     EISSN: 19348290     Source Type: Journal    
DOI: 10.1002/0471141755.ph1430s66     Document Type: Article

References (40)

1. AACR Cancer Progress Report Writing Committee, Sawyers, C.L., Abate-Shen, C., Anderson, K.C., Barker, A., Baselga, J., Berger, N.A., Foti, M., Jemal, A., Lawrence, T.S., Li, C.I., Mardis, E.R., Neumann, P.J., Pardoll, D.M., Prendergast, G.C., Reed, J.C., and Weiner, G.J. 2013. AACR Cancer Progress Report 2013. Clin. Cancer Res. 19:S4-S98.
2. Alkofer, B., Lepennec, V., and Chiche, L. 2011. Hepatocellular cancer in the non-cirrhotic liver. J. Visc. Surg. 148:3-11.
3. Aravalli, R.N., Cressman, E.N., and Steer, C.J. 2013. Cellular and molecular mechanisms of hepatocellular carcinoma: an update. Arch. Toxicol. 87:227-247.
4. Bannasch, P. 1983. Strain and species differences in susceptibility to liver tumour induction. IARC Sci. Publ. 51:9-38.
5. Becker, F.F. 1983. Thioacetamide hepatocarcinogenesis. J. Natl. Cancer Inst. 71:553-558.
6. Bucher, J.R. 1998. Update on national toxicology program (NTP) assays with genetically altered or "transgenic" mice. Environ. Health Perspect. 106:619-621.
7. Center, M.M. and Jemal, A. 2011. International trends in liver cancer incidence rates. Cancer Epidemiol. Biomarkers Prev. 20:2362-2368.
8. Chappell, G., Kutanzi, K., Uehara, T., Tryndyak, V., Hong, H.H., Hoenerhoff, M., Beland, F.A., Rusyn, I., and Pogribny, I.P. 2014. Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice. Int. J. Cancer 134:2778-2788.
9. Dapito, D.H., Mencin, A., Gwak, G.Y., Pradere, J.P., Jang, M.K., Mederacke, I., Caviglia, J.M., Khiabanian, H., Adeyemi, A., Bataller, R., Lefkowitch, J.H., Bower, M., Friedman, R., Sartor, R.B., Rabadan, R., and Schwabe, R.F. 2012. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21:504-516.
10. Della Corte, C. and Colombo, M. 2012. Surveillance for hepatocellular carcinoma. Semin. Oncol. 39:384-398.
11. Dragani, T.A., Manenti, G., and Della, P.G. 1986. Enhancing effects of carbon tetrachloride in mouse hepatocarcinogenesis. Cancer Lett. 31:171-179.
12. Druckrey, H., Steinhoff, D., Preussmann, R., and Ivankovic, S. 1964. Induction of cancer by a single dose of methylnitroso-urea and various dialkylnitrosamines in rats. Z. Krebsforsch. 66:1-10.
13. El Serag, H.B. and Rudolph, K.L. 2007. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology 132:2557-2576.
14. Farazi, P.A. and DePinho, R.A. 2006. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat. Rev. Cancer 6:674-687.
15. Fattovich, G., Stroffolini, T., Zagni, I., and Donato, F. 2004. Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology 127:S35-S50.
16. Fausto, N. and Campbell, J.S. 2010. Mouse models of hepatocellular carcinoma. Semin. Liver Dis. 30:87-98.
17. Fujii, T., Fuchs, B.C., Yamada, S., Lauwers, G.Y., Kulu, Y., Goodwin, J.M., Lanuti, M., and Tanabe, K.K. 2010. Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor. BMC Gastroenterol. 10:79.
18. Goldsworthy, T.L. and Fransson-Steen, R. 2002. Quantitation of the cancer process in C57BL/6J, B6C3F1 and C3H/HeJ mice. Toxicol. Pathol. 30:97-105.
19. Grivennikov, S.I., Greten, F.R., and Karin, M. 2010. Immunity, inflammation, and cancer. Cell 140:883-899.
20. Guzman, G., Chennuri, R., Voros, A., Boumendjel, R., Locante, A., Patel, R., and Valyi-Nagy, T. 2011. Nucleometric study of anisonucleosis, diabetes and oxidative damage in liver biopsies of orthotopic liver transplant recipients with chronic hepatitis C virus infection. Pathol. Oncol. Res. 17:191-199.
21. Heindryckx, F., Colle, I., and Van Vlierberghe, H. 2009. Experimental mouse models for hepatocellular carcinoma research. Int. J. Exp. Pathol. 90:367-386.
22. Hoenerhoff, M.J., Hong, H.H., Ton, T.V., Lahousse, S.A., and Sills, R.C. 2009. A review of the molecular mechanisms of chemically induced neoplasia in rat and mouse models in National Toxicology Program bioassays and their relevance to human cancer. Toxicol. Pathol. 37:835-848.
23. Huff, J., Cirvello, J., Haseman, J., and Bucher, J. 1991. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ. Health Perspect. 93:247-270.
24. Jacobson-Kram, D. 2010. Cancer risk assessment approaches at the FDA/CDER: Is the era of the 2-year bioassay drawing to a close? Toxicol. Pathol. 38:169-170.
25. Jepsen, P., Vilstrup, H., Tarone, R.E., Friis, S., and Sorensen, H.T. 2007. Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trends. Int. J. Cancer 121:1624-1626.
26. Luedde, T. and Schwabe, R.F. 2011. NF-kappaB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol. Hepatol. 8:108-118.
27. Maeda, S., Kamata, H., Luo, J.L., Leffert, H., and Karin, M. 2005. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121:977-990.
28. Masson, P.J. 1929. Some histological methods: Trichrome stainings and their preliminary technique. Tech. Methods 12:75-90.
29. Mitchell, K.A. 2013. Hepatocellular carcinoma: Histologic considerations: Pure, mixed, and motley. J. Clin. Gastroenterol. 47:S20-S26.
30. National Research Council. 2005. Prudent Practices in the Laboratory: Handling and Disposal of Chemicals. The National Academies Press, Washington, D.C.
31. National Toxicology Program. 2011. 12th Report on Carcinogens. Department of Health and Human Services, Research Ttiangle Park, North Carolina.
32. Oh, J.Y., Jeong, J.S., Kim, Y.J., Nam, K.J., Park, B.H., Kwon, E.Y., Kim, Y.H., and Hwang, T.H. 2002. Ultrasonographic evidence of phenotypic instability during hepatocarcinogenesis in N-nitrosomorpholine-treated rats. Exp. Mol. Pathol. 73:67-73.
33. Siegel, R., Naishadham, D., and Jemal, A. 2013. Cancer statistics, 2013. CA Cancer J. Clin. 63:11-30.
34. Stowell, R.E., Lee, C.S., Tsuboi, K.K., and Villasana, A. 1951. Histochemical and microchemical changes in experimental cirrhosis and hepatoma formation in mice by carbon tetrachloride. Cancer Res. 11:345-354.
35. Titford, M. 2005. The long history of hematoxylin. Biotech. Histochem. 80:73-78.
36. Uehara, T., Ainslie, G.R., Kutanzi, K., Pogribny, I.P., Muskhelishvili, L., Izawa, T., Yamate, J., Kosyk, O., Shymonyak, S., Bradford, B.U., Boorman, G.A., Bataller, R., and Rusyn, I. 2013. Molecular mechanisms of fibrosis-associated promotion of liver carcinogenesis. Toxicol. Sci. 132:53-63.
37. Vesselinovitch, S.D. and Mihailovich, N. 1983. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res. 43:4253-4259.
38. Vucur, M., Roderburg, C., Bettermann, K., Tacke, F., Heikenwalder, M., Trautwein, C., and Luedde, T. 2010. Mouse models of hepatocarcinogenesis: What can we learn for the prevention of human hepatocellular carcinoma? Oncotarget 1:373-378.
39. Wells, M.Y. and Williams, E.S. 2009. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies-implications for REACH. Regul. Toxicol. Pharmacol. 53:150-155.
40. Zucman-Rossi, J. 2010. Molecular classification of hepatocellular carcinoma. Dig. Liver Dis. 42:S235-S241.